Charles River Laboratories International Income Statement (2009-2025) | CRL

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Apr2023	Jul2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Revenue & cost
Revenue (Quarter)	824.57M	914.61M	895.94M	905.05M	913.93M	973.13M	989.16M	1,099.84M	1,029.37M	1,059.94M	1,026.62M	1,013.48M	1,011.56M	1,026.12M	1,009.76M	1,002.55M	984.17M	1,032.13M	1,004.85M	994.23M
Cost of Revenue (Quarter)	423.98M	95.82M	90.05M	-1001.36M	486.86M	522.62M	88.23M	603.12M	651.72M	660.96M	664.78M	318.52M	417.91M	577.38M	137.91M	1,365.64M	577.43M	584.88M	408.11M	249.28M
Gross Profit (Quarter)	400.59M	818.78M	805.89M	1,906.41M	427.06M	450.51M	900.93M	496.72M	377.65M	398.98M	361.84M	694.96M	593.65M	448.73M	871.86M	-363.09M	406.74M	447.26M	596.74M	744.94M
Operating items
Amortization - Intangibles (Quarter)	28.84M	32.97M	32.85M	30.24M	38.01M	37.60M	35.53M	35.46M	34.90M	34.30M	34.20M	34.00M	32.58M	32.30M	32.40M	41.25M	65.26M	65.38M	27.40M	21.00M
Selling, General & Administrative (Quarter)	155.73M	171.50M	148.57M	144.11M	150.03M	131.71M	183.71M	199.64M	174.85M	199.76M	176.11M	197.14M	186.29M	169.79M	199.21M	195.71M	177.80M	191.55M	177.59M	196.14M
Restructuring Costs (Quarter)
Operating Expenses (Quarter)	155.73M	171.50M	148.57M	144.11M	150.03M	131.71M	183.71M	199.64M	174.85M	199.76M	176.11M	197.14M	186.29M	169.79M	199.21M	195.71M	177.80M	191.55M	177.59M	196.14M
Operating Income (Quarter)	123.70M	137.55M	155.80M	172.81M	148.78M	187.41M	150.98M	163.81M	167.89M	164.94M	151.50M	132.92M	125.98M	151.65M	117.41M	-167.69M	74.67M	100.13M	133.80M	-283.44M
EBIT (Quarter)	123.70M	137.55M	155.80M	172.81M	148.78M	187.41M	150.98M	163.81M	167.89M	164.94M	151.50M	132.92M	125.98M	151.65M	117.41M	-167.69M	74.67M	100.13M	133.80M	-283.44M
Non-operating items
Interest & Investment Income (Quarter)	0.04M	0.17M	0.14M	0.31M	0.13M	0.19M	0.12M	0.34M	0.81M	1.43M	1.37M	1.59M	2.20M	3.01M	1.53M	1.83M	1.40M	1.10M	1.42M	1.02M
Other Non Operating Income (Quarter)	-27.72M	5.96M	-16.21M	2.07M	-28.62M	-39.78M	-16.62M	115.55M	-3.28M	-2.66M	-6.26M	107.74M	5.83M	-2.24M	2.59M	-22.70M	-12.21M	0.15M	-22.62M	12.10M
Non Operating Income (Quarter)	-27.72M	5.96M	-16.21M	2.07M	-28.62M	-39.78M	-16.62M	115.55M	-3.28M	-2.66M	-6.26M	107.74M	5.83M	-2.24M	2.59M	-22.70M	-12.21M	0.15M	-22.62M	12.10M
Net income details
EBT (Quarter)	66.30M	127.50M	123.27M	163.64M	110.85M	144.11M	123.11M	244.92M	131.04M	128.66M	112.87M	208.71M	99.01M	119.65M	91.24M	-216.79M	35.98M	71.42M	87.20M	-294.10M
Tax Provisions (Quarter)	2.37M	37.58M	18.11M	23.82M	15.62M	33.45M	25.50M	55.81M	27.09M	29.22M	24.85M	19.75M	24.53M	25.39M	20.95M	-3.04M	10.10M	18.73M	31.64M	-17.81M
Profit After Tax (Quarter)	61.53M	88.45M	103.43M	145.43M	95.23M	110.66M	96.47M	182.72M	103.13M	99.44M	88.02M	187.08M	72.96M	94.26M	69.66M	-214.50M	25.88M	52.69M	54.42M	-278.46M
Equity Income (Quarter)
Net Income - Minority (Quarter)
Income from Non-Controlling Interests (Quarter)	2.40M	1.47M	1.73M	2.25M	2.20M	1.34M	1.14M	1.70M	0.82M	2.42M	0.63M	1.87M	1.52M	0.18M	0.64M	0.75M	0.41M	0.37M	1.13M	0.27M
Income from Continuing Operations (Quarter)	63.94M	89.92M	105.16M	139.83M	95.23M	110.66M	97.61M	189.11M	103.95M	99.44M	88.02M	188.95M	74.48M	94.26M	70.30M	-213.75M	25.88M	52.69M	55.56M	-276.29M
Consolidated Net Income (Quarter)	63.94M	89.92M	105.16M	139.83M	95.23M	110.66M	97.61M	189.11M	103.95M	99.44M	88.02M	188.95M	74.48M	94.26M	70.30M	-213.75M	25.88M	52.69M	55.56M	-276.29M
Income towards Parent Company (Quarter)	63.94M	89.92M	105.16M	139.83M	95.23M	110.66M	97.61M	189.11M	103.95M	99.44M	88.02M	188.95M	74.48M	94.26M	70.30M	-213.75M	25.88M	52.69M	55.56M	-276.29M
Net Income towards Common Stockholders (Quarter)	63.94M	89.92M	105.16M	139.83M	95.23M	110.66M	97.61M	189.11M	103.13M	97.02M	87.39M	187.08M	67.33M	89.99M	68.68M	-215.70M	25.47M	52.33M	54.42M	-276.56M
Additional items
EPS (Basic) (Quarter)	1.23	1.76	2.05	2.73	1.84	2.15	1.90	3.69	2.02	1.89	1.70	3.65	1.31	1.75	1.34	-4.19	0.50	1.06	1.11	-5.57
EPS (Weighted Average and Diluted) (Quarter)	1.20	1.72	2.01	2.67	1.81	2.13	1.88	3.65	2.01	1.89	1.69	3.64	1.30	1.74	1.33	-4.17	0.50	1.06	1.10	-5.56
Shares Outstanding (Weighted Average) (Quarter)	49.98M	50.14M	50.23M	50.29M	50.64M	50.73M	50.78M	50.81M	51.10M	51.16M	51.28M	51.23M	51.44M	51.49M	51.46M	51.38M	50.68M	49.91M	49.68M	49.56M
Shares Outstanding (Diluted Average) (Quarter)	51.08M	51.33M	51.56M	51.42M	51.33M	51.28M	51.28M	51.30M	51.43M	51.38M	51.61M	51.45M	51.84M	51.85M	51.71M	51.63M	50.85M	50.09M	49.43M	49.56M
EBITDA (Quarter)	123.70M	137.55M	155.80M	172.81M	148.78M	187.41M	150.98M	163.81M	167.89M	164.94M	151.50M	132.92M	125.98M	151.65M	117.41M	-167.69M	74.67M	100.13M	133.80M	-283.44M
Interest Expenses (Quarter)	29.72M	16.19M	16.45M	11.55M	9.43M	3.70M	11.38M	34.78M	34.38M	35.04M	33.74M	33.54M	35.00M	32.77M	30.28M	28.23M	27.88M	29.97M	25.40M	23.77M
Tax Rate (Quarter)	3.57%	29.48%	14.69%	14.55%	14.09%	23.21%	20.71%	22.79%	20.67%	22.71%	22.02%	9.46%	24.77%	21.22%	22.96%	1.40%	28.07%	26.22%	36.29%	6.06%

Research Tools

Charles River Laboratories International Income Statement (2009-2025) | CRL

Create an account

Sign In

Reset Password